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Abstract
Background: The muscle layers of murine gastric fundus have no interstitial cells of Cajal at the
level of the myenteric plexus and only possess intramuscular interstitial cells and this tissue does
not generate electric slow waves. The absence of intramuscular interstitial cells in W/WV mutants
provides a unique opportunity to study the molecular changes that are associated with the loss of
these intercalating cells.
Method: The gene expression profile of the gastric fundus of wild type and W/WV mice was
assayed by murine microarray analysis displaying a total of 8734 elements. Queried genes from the
microarray analysis were confirmed by semi-quantitative reverse transcription-polymerase chain
reaction.
Results: Twenty-one genes were differentially expressed in wild type and W/WV mice. Eleven
transcripts had 2.0–2.5 fold higher mRNA expression in W/WV gastric fundus when compared to
wild type tissues. Ten transcripts had 2.1–3.9 fold lower expression in W/WV  mutants in
comparison with wild type animals. None of these genes have ever been implicated in any bowel
motility function.
Conclusions:  These data provides evidence that several important genes have significantly
changed in the murine fundus of W/WV mutants that lack intramuscular interstitial cells of Cajal and
have reduced enteric motor neurotransmission.
Background
Interstitial cells of Cajal (ICC) are gastrointestinal (GI)
pacemaker cells and intermediaries in enteric motor neu-
rotransmission in the GI tract [1,2]. ICC express KIT/c-kit
and depend on signalling via the gene product protein,
KIT, a receptor tyrosine kinase which is essential for devel-
opment and maintenance of the ICC phenotype [3].
Mutations in the white-spotting locus (i.e. W/WV) result in
reduced KIT expression. These mutant animals develop
few ICC at the level of the myenteric plexus (IC-MY) in the
small intestine and the reduced ICC numbers is associated
with a loss of slow wave activity. Intramuscular ICC (IC-
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IM) located in the stomach, lower esophageal and pyloric
sphincters are absent in W/WV  mutant animals [4].
Reduced numbers of ICC have also been reported in sev-
eral GI motility disorders, such as chronic intestinal
pseudo-obstruction [5,6], infantile hypertrophic pyloric
stenosis [7–9], Hirschsprung's disease [10–12], slow-tran-
sit constipation and certain forms of gastroparesis [13,14].
The association between motility disorders and loss of
specific populations of ICC suggests that a more complete
understanding of the molecular and cell biology of ICC
networks within the gastrointestinal tract may help in
understanding the etiology of some GI motor patholo-
gies. The aim of the present study was to characterize
genetic sequences that are expressed in ICC of the stom-
ach that may encode important functional elements of the
GI pacemaker/motor neurotransmission system. We pur-
sued the hypothesis that such genes might show differen-
tial expression in the small intestines of wild type mice
and W/WV mice [15,16]. We previously identified fifteen
known and novel genes that were differentially expressed
in the small intestines of wild type and W/WV mice, which
develop few IC-MY using a differential gene expression
method [17,18].
In the present study we hypothesized that there may also
be differential expression of genes in the gastric fundus of
W/WV mice, where IC-IM are lost. Our gene microarray
analysis successfully identified 21 genes that were differ-
entially expressed in the fundus of W/WV mice. The differ-
ential expression of these mice was confirmed by semi-
quantitative reverse transcription-polymerase chain reac-
tion (RT-PCR).
Methods
Animals and Tissue Preparation
The use and treatment of experimental animals was
approved by the Guideline governing Animal Experiment
Committee at the University of Yamanashi School of
Medicine and at the University of Nevada School of Med-
icine. Six adult male WBB6F1-+/+ mice (wild type) and
age matched six adult male WBB6F1-W/WV mice, weigh-
ing 20 to 30 g, were purchased from Japan SLC Inc (Shi-
zuoka, Japan). They were anesthetized with ether or
carbon dioxide inhalation and sacrificed by cervical dislo-
cation. For gene analyses, stomachs were removed from
the animal and the mucosa with the attached submucosa
rapidly sharp dissected from the tunica muscularis. Tissues
were subsequently frozen in liquid nitrogen (-196 °C).
Tissues were stored at -80 °C until isolation of RNA was
preformed [18].
RNA Preparation and Microarray Data Analysis
For gene microarray analysis, poly (A)+ RNA was isolated
from each tissue sample by TRIZOL (Life Technologies,
Inc., Gaithersburg, MD, USA) and Poly (A)+Isolation Kit
from Total RNA (ISOGEN, Nippon Gene, Tokyo,
Japan).18 Before starting microarray analysis, differential
gene expression of KIT between the gastric fundic tissues
of wild type mice and those of W/WV mutant mice were
confirmed by semi-quantitative RT-PCR (See the section
of Semi-quantitative RT-PCR) (Fig. 1A). Microarrays were
hybridized and scanned, and image analysis was per-
formed as described previously [19,20]. In brief, altera-
tions in gene expression were evaluated by reverse
transcription of poly (A)+ RNAs in the presence of Cy3 or
Cy5 fluorochromes followed by hybridization to mouse
GEM 1 microarray chips (Incyte Genomics, Inc., Porter
Drive Palo Alto, CA, USA). To confirm the validity of the
assay, the experiments were performed in duplicate. The
8734 cDNAs we used represent 7854 unique genes/Uni-
Gene clusters: 3205 are annotated and 4649 are unanno-
tated sequences. We assigned a cut-off value, using a
variance analysis, to the microarray slide. Genes whose
Cy3- and Cy5-signal intensities were lower than the cut-
off values were excluded from further investigation. Bal-
anced differential expression was determined for control
wild type mice versus W/WV mutant mice. Values that
were < -2.0 or > 2.0 in both two independent experiments
were considered significant and the mean values of the
relative fluorescence ratio for each gene were calculated.
Semi-quantitative RT-PCR
The levels of mRNA expression that were decreased or
increased by > 2.0-fold or greater, were confirmed by
semi-quantitative RT-PCR from fundus of 6 of each wild
type mice and W/WV mice. RT-PCR was performed as
described previously [18]. In brief, 2 µg aliquots of total
RNAs treated with DNase I (Roche Diagnostics, Basel,
Switzerland) from the mice fundic tissues were used to
synthesize single-strand cDNAs. These cDNAs were used
as templates for PCR in a thermal cycler (PerkinElmer,
Shelton, CT, USA), using primers listed in Table 1 or KIT
(5'-ATG ACG TCA TGA AGA CTT GCT-3' and 5'-CTA CCC
TGG AAT AGG ATG CA-3'), and GAPDH specific primer
sets (5'-GACAACAGCCTCAAGATCATCA-3' and 5'-
GGTCCACCACTGACACTGTG-3'). Expression of GAPDH
served as an internal control. Primers were derived from
different exons in the same gene, when the corresponding
mouse genomic sequence was available at that time. The
PCR reactions were optimized for number of cycles to
ensure product intensity within the linear phase of
amplification.
Results
Microarray Analysis and Semi-quantitative RT-PCR
To identify genes that may be selectively associated with
IC-IM, we compared gene expression patterns in gastric
fundic tissues derived from wild type and W/WV mice uti-
lizing a gene microarray method [19,20]. Murine fundusBMC Gastroenterology 2003, 3 http://www.biomedcentral.com/1471-230X/3/14
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without epithelial tissues derived from wild type and W/
WV mice maintained under fasted conditions were used to
generate poly (A)+ mRNA for microarray analysis using
the mouse GEM 1 microarray. Results of this experiment,
highlighting genes that were reproducibly decreased or
increased by > 2.0-fold or greater, are shown in Table 2
and Fig. 1B. Several known and novel genes were differen-
tially expressed in the fundus of W/WV mice ( > 2.0 bal-
anced differential expression). To confirm the differential
expression profiles, we further examined the expression
levels in murine fundic mRNA derived from wild types
and W/WV mice maintained under fasted conditions as
templates, using semi-quantitative RT-PCR analysis (Rep-
resentative data were shown in Fig. 1C,1D. All primer sets
used for the confirmation were listed in Table 1). Expres-
sion of ten genes was considerably reduced in the gastric
fundus of W/WV mice compared to age matched wild type
mice. Another eleven genes showed an increase in expres-
sion in fasted W/WV mice.
Discussion
A comparison of differentially expressed genes from the
fundus of W/WV mice using DNA microarray analysis
revealed that the expression of eleven genes transcripts
were significantly up-regulated in W/WV mice, whereas
ten genes transcripts were dramatically suppressed in
these animals. We confirmed these results with semi-
quantitative RT-PCR of tissues from six each of wild type
and W/WV mice. Data obtained from these experiments
suggest that expression of the genes were specifically regu-
lated in W/WV mice.
The eleven genes that were up-regulated in the gastric fun-
dus of W/WV  mice were identified as MCM7,  p160
ROCK2, BST1/BP3, RBP2, and another seven unannotated
transcripts. MCM7 is a mammalian homologue of the
yeast nuclear protein MCM2/CDC47, which is thought to
play an important role in two crucial steps of the cell cycle,
namely, onset of DNA replication and cell division
[21,22]. p160 ROCK2, which is an isozyme of ROCK1 is
a target for the small GTPase, Rho [23]. ROCK2 is a serine/
threonine kinase that regulates cytokinesis, smooth mus-
cle contraction, the formation of actin stress fibers and
focal adhesions, and the activation of the FOS serum
response element [24]. The up-regulation of p160 ROCK2
may have a compensating effect for the loss of ICC-
dependent mechanisms in the gastric fundus. The BST1/
BP3, a bone marrow stromal cell surface antigen, is a var-
iably glycosylated glycosyl-phosphatidylinositol (GPI)-
linked molecule that is selectively expressed by early B and
T lineage cells and a discrete subpopulation of reticular
cells in the peripheral lymphoid organs. It is also
expressed on the brush border of intestinal epithelial cells,
the luminal surface of renal collecting tubules and mature
myeloid cells [25]. This protein is supposed to belong to
ADP-ribosyl cyclase family [26]. Cellular RBP2 is an abun-
dant 134-residue protein present in the small intestinal
epithelium [27]. It is thought to participate in the uptake
Figure 1
A. Expression of KIT gene using semi-quantitative RT-PCR, in 
gastric fundic tissues from wild type and W/WV mutant mice 
maintained under fasted conditions. GAPDH levels were 
measured as a control. B. Representative image of DNA 
microarray hybridization. Alterations in gene expression that 
were represented by the ratio of intensity of fluorescence 
measured using Cy3 and Cy5 fluorochromes. Expression 
profiles were evaluated by reverse transcription of poly (A)+ 
RNAs from gastric fundic muscles from wild type and W/WV 
mice in the presence of Cy3 or Cy5 fluorescent labeling dyes 
followed by hybridization to mouse GEM 1 microarrays. The 
image shown was produced by superimposing the Cy5 fluo-
rescence image (pseudo-coloured green that represents 
expression level of RNA from the tunica muscularis of W/WV 
fundus) and the Cy3 fluorescence image (pseudo-coloured 
red that represents RNA expression from wild type tissues). 
Arrays were counterstained with DAPI (blue). C. Confirma-
tion of the reliability of the microarray data by semi-quantita-
tive RT-PCR. Representative examples of RT-PCR analysis, in 
fundic tissues from six wild type and six W/WV mutant mice 
maintained under starved conditions. Expression of the CPO 
gene was considerably reduced in the fundus of W/WV mice 
compared to age matched wild type mice, whereas the 
MCM7 gene showed an increase in expression in W/WV mice. 
D. Relative expression level of CPO (CPO/GAPDH) and MCM7 
(MCM7/GAPDH) in fundic tissues from six wild type and six 
W/WV mutant mice. The data represent the mean ( ± SD) of 
six different RT-PCR experiments using six wild type or W/
WV fundus RNA as templates.
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Table 1: Primer sets used for semi-quantitative RT-PCR.
Gene Name Accession No. Forward Primer Reverse Primer
EST AA185701 CGA AAG CCT TGA GGT TGA AG TAG GAA AAC AGG CGT CAC TG
EST AA166336 GAA GAA AAG GCT GCA GAT CG CAA GAG GCA AAG AGC AAT CC
EST AA021806 CAC GAA TTG CAG GAC TAC CT ACC TGC ACT GTA GGC TGA GT
MCM7 Q61881 GCC CAC TGG ATT GTG AAG AT AGG AGA CTG GTC CAC ACC AC
p160 ROCK2 U58513 AAG AAC CTG TCA AGC GTG GT TCC AGG GTC ATC TGG AGT TC
EST W18585 AGA CTT GGT GGC AGA GGA GA GCA GCT CAT GAC AGA ACA CC
EST AA403748 CCT AAA GCA ACC CAA CCT GA TAG CCT TAT GGG ACC TGG TG
BST1/BP3 Q64277 GAT TTC TTG AGC TGG TGT CG AAA ACC CTC TCG TGG GAT AG
EST AA024250 CAG ATA GAG CAA GGG ATG GA CTG AGC CCA AAC CAG TAG AA
RBP2 Q08652 GAC GAA GGA CCA AAA TGG AA CGG TGA AAT CCA GGT CGT AG
EST W46016 AGC AAC AAC AGC TGG ACT TC ACC TTC TGT TTG GTG CTG AG
BP1/6C3 S30398 TAT CGG CCT CAT CTA ACC AG ATC TTC AAG CAG CAC CTG AC
EST AI552444 CAT GCG ATA CTG GAA CAT GA TGA CTC CAA ATA GCC CTC AG
EST AA108876 TGG AGC AAG AGA GGA AAG TG CTA GAC CTG AGC TTG CCT TG
EST AA049294 ACG TGG AGA AAG TTC TCG TG GCA ATA GTG TCA CCG AAT CC
EST AA254777 GCC CTG GAG TTG AGA CTG TA TGA CAA GCT GCA CAG TAA CC
RHAMM AF031932 GCA GAA GGA GGA GCA GAG TG GCA GTG ACG TCC CTC AGA CT
EST AA002293 AAG TCT TTG TGT GGG CTG AG AGG AAG CTT CGT CTC TCC AT
EST AI595081 CAC CAG GAT GTC TGC CTA CT CCG AGA TCA TGT TCT TCA CC
CPO D16333 GAA GAC CAA GAT GGA GCT GA CAG AAA GAT TCC CAT GAA CG
EST AA000304 TTC ATC TGC TGC TCC TTC TC TTA TAG ACC TTC CCG CAC AG
Table 2: Analysis of gene expression in the fundus of wild type and W/WV mice
Gene Name W/WV/wildtype ratio(a) Accession No. Subcellular location(b) Cytoband(c)
EST 2.5 AA185701
EST 2.5 AA166336
EST 2.4 AA021806
MCM7: DNA Replication Licensing Factor 2.4 Q61881 nucleus 7q21.3-q22.1
p160 ROCK2: Rho-Associated Protein Kinase 2.3 U58513 cytoskeleton 2p24
EST 2.3 W18585
EST 2.3 AA403748
BST1/BP3: ADP-Ribosyl Cyclase 2 Precursor 2.0 Q64277 membrane 4p15
EST 2.0 AA024250
RBP2: retinol binding protein 2, cellular 2.0 Q08652 cytoplasm 3q23
EST 2.0 W46016
BP1/6C3: Glutamyl Aminopeptitase -2.1 S30398 membrane 16
EST -2.2 AI552444
EST -2.3 AA108876
EST -2.4 AA049294
EST -2.4 AA254777
RHAMM: Hyaluronan-Mediated Motility Receptor -2.5 AF031932 membrane 5q33.2-qter
EST -2.5 AA002293
EST -3.4 AI595081
CPO: Coproporphyrinogen Oxidase -3.6 D16333 mitochondria 3q12
EST -3.9 AA000304
(a) Balanced differential expression for control wild type mice vs W/W V mutant mice. Values that were decreased or increased by > 2-fold or 
greater in both two independent experiments were considered significant and the mean values were calculated. All of the results were confirmed 
with semi-quantitative RT-PCR using fundic tissues from six wild type and six W/WV mutant mice. (b) Subcellular location determined by the 
SOURCE program http://source.stanford.edu. (c) Human chromosomal localization of the gene.BMC Gastroenterology 2003, 3 http://www.biomedcentral.com/1471-230X/3/14
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and/or intracellular metabolism of vitamin A and belong
to a protein family that contains liver fatty acid-binding
protein. Vitamin A is a fat-soluble vitamin necessary for
growth, reproduction, differentiation of epithelial tissues,
and vision. Mammals depend on intestinal absorption of
this vitamin for their survival. RBP2, which is confined
largely to the small intestinal enterocyte, probably plays
an important role in the intestinal absorption and/or
metabolism of vitamin A [27].
We also confirmed the down-regulation of ten genes in
W/WV mice: BP1/6C3, RHAMM, CPO, and another seven
unannotated ESTs. The murine β-lymphocyte differentia-
tion antigen, BP1/6C3 was characterized as glutamyl ami-
nopeptidase, which is reported to serve as cell-
differentiation marker of lymphomyelocytic lineages and
may be involved in cell activation, signal transduction,
and cell-matrix adhesion. It is also expressed by capillary
endothelial cells, placenta, and epithelial cells of the intes-
tine and proximal renal tubules [28]. RHAMM encodes a
hyaluronan receptor protein [29]. When hyaluronan
binds to RHAMM, the phosphorylation of a number of
proteins including the focal adhesion kinase pp125-FAK
occurs [30]. This is a necessary step for disassembly of
focal contacts and subsequent motility. CPO is the sixth
enzyme of the heme biosynthetic pathway. This soluble
protein is localized in the intermembrane space of mito-
chondria and catalyzes the conversion of two propionate
groups at positions two and four of coproporphyrinogen
III to two vinyl groups of protoporphyrinogen IX [31]. It
was reported that coproporphyria (CPO deficiency)
patients showed constipation and abnormal colic that are
main symptoms of this disease [32]. Marked elevation of
coproporphyria in the feces differentiated the condition
from the Swedish type in which stool porphyrins are usu-
ally normal and from variegate porphyria in which both
coproporphyrin and protoporphyrinogen fractions are
increased in the stool [33].
In the 21 genes identified, we determined the subcellular
localization and human chromosomal mapping of the 7
known genes using the SOURCE program http://
source.stanford.edu (Table 2). These genes showed a vari-
ety of cellular localization including 3 membrane, 2 cyto-
plasmic, 1 mitochondrial and 1 nuclear proteins. Further
analyses of these genes might enable us to elucidate not
only their relationship with the KIT, a receptor tyrosine
kinase, but also the molecular aspects of GI pacemaker
system.
We previously identified fifteen genes that were differen-
tially expressed in the small intestines of wild type and W/
WV mice which develop few IC-MY using a differential
gene expression method [17,18].™@None of these 15
genes were found in the list of 21 genes that were differen-
tially expressed in the gastric fundus of wild type and W/
WV mice which develop few IC-IM using a cDNA microar-
ray. As we confirmed differential gene expression of KIT
between the small intestines/gastric fundic tissues of wild
type and those of W/WV mutant mice by semi-quantitative
RT-PCR, our experimental system could detect genetic
aberration in W/WV mice. Therefore our results might
reflect the difference of the cellular entity of two types of
ICCs, IC-MY and IC-IM, or the difference of the cellular
composition between small intestine and fundus. To pro-
vide conclusive evidence, which support these specula-
tions, expression profile using purified mRNA from
isolated single interstitial cells might be very useful in the
next study.
At the present time we do not know whether these genes
are important to the function of the gastric pacemaker/
neurotransmission apparatus or were down- or up-regu-
lated as a result of the loss of ICC. These data, however,
provide clear systemic genetic evidence that several
important proteins that have roles in cell cycle, cytokine-
sis and formation of cytoskeleton, cellular metabolism,
oxygen metabolism, cell adhesion, and development and
differentiation of gut cells are significantly changed in the
gastric fundus of W/WV mice. Generation of transgenic
animals that show tissue-specific overexpression of the
candidate genes, as well as the gene knockout animals
might be helpful for elucidating the role of each gene in
gastrointestinal motility.
The discovery of an entire human and mouse genes
through the genome project is supposed to revolutionize
biological medicine including molecular diagnosis of var-
ious diseases and development of novel treatment. The
information combined with high throughput technology
such as DNA microarray and SNP typing analysis will
accelerate discovery of genes susceptible to or causing var-
ious diseases and contribute to screening of novel drugs
that target these disease-gene products. In this sense, the
effort of the molecular profiling project in which we
attempt to discover genetic aberration in animal disease
models such as W/WV mice will generate very variable
resources for further elucidation of motility disorders. As
reduced numbers of ICC have also been reported in sev-
eral GI motility disorders, such as chronic intestinal
pseudo-obstruction [5,6], slow-transit constipation and
certain forms of gastroparesis [13,14], these gene informa-
tion should aid the development of novel molecular-tar-
geted therapies for these disorders, and may also identify
diagnostic molecular markers for these disorders.
Conclusion
We have identified twenty-one genes that encode func-
tional proteins that are significantly up- or down-regu-
lated in the tunica muscularis of the gastric fundus of W/WVBMC Gastroenterology 2003, 3 http://www.biomedcentral.com/1471-230X/3/14
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mice. Considering that none of these genes has been
implicated in any aspect of GI motility, we suggest that
many unknown genes could be involved in the cellular
changes that lead to motility disorders associated with the
loss of ICC. Gene microarray analysis is an effective
method for screening the changes that occur in the
expression patterns of genes in response to spontaneous
or genetic mutations that lead to the loss of a specific cell
type. Application of this technique may allow recognition
of patterns of gene expression that are common to the
several motility disorders in which ICC are lost, thus pro-
viding new insights into the molecular mechanisms
responsible for the selective loss of ICC populations.
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